The global cocaine intoxication treatment market is projected to achieve a valuation of USD 10 million in 2023 and is expected to grow significantly, reaching approximately USD 17.91 million by 2033. This growth represents a compound annual growth rate (CAGR) of 6% over the forecast period from 2023 to 2033. The market demonstrated steady growth in the historical period from 2018 to 2022, with a recorded CAGR of 4%.
The increasing prevalence of cocaine use and the associated health risks have underscored the urgent need for effective treatment options. As awareness of addiction and its impact on individuals and communities grows, healthcare providers are focusing on developing and implementing comprehensive treatment strategies for cocaine intoxication.
Key drivers of market growth include the rising demand for evidence-based treatment methods, advancements in addiction therapy, and increasing investments in research and development to improve therapeutic outcomes for individuals affected by cocaine use.
North America currently dominates the cocaine intoxication treatment market, thanks to a well-established healthcare infrastructure and ongoing initiatives to combat substance abuse. Additionally, the Asia-Pacific region is emerging as a potential growth area, driven by rising awareness of addiction treatment and expanding healthcare services.
As the fight against cocaine addiction intensifies, the cocaine intoxication treatment market is well-positioned for growth. Industry players are expected to prioritize innovation, enhance treatment protocols, and foster collaborations to improve access to effective treatment options for those in need.
2018 to 2022 Cocaine Intoxication Treatment Market Demand Analysis vs. Forecast 2023 to 2033
According to market research and competitive intelligence provider, Future Market Insights- the market for Cocaine Intoxication Treatment reflected a value of 4% during the historical period, 2018 to 2022.
The market for Cocaine Intoxication Treatment is gaining prominence as Cocaine is a highly addictive stimulant drug that can cause serious health problems, including overdose and death. Furthermore, due to the rarity of the disease, there is ongoing research into developing new treatments for Cocaine Intoxication Treatment, expected to drive demand for these treatments. The treatment for cocaine intoxication usually involves managing the symptoms and providing supportive care, such as monitoring the patient’s vital signs, addressing any medical complications that may arise, and providing psychological support.
The development of new treatments is a high priority for the medical community due to the devastating effects of the disease and the limited treatment options available. As more effective treatments become available, the market for Cocaine Intoxication Treatment is likely to grow. In the years to come, increasing focus by government organizations and private agencies like WHO and pharmaceutical companies to create awareness of Cocaine Intoxication Treatment is fuelling the market growth. Thus, the market for Cocaine Intoxication Treatment is expected to register a CAGR of 6% in the forecast period 2023 to 2033.
Market Competition
Key players in the market include companies such as Tonix Pharmaceutical, GlaxoSmithKline Plc., Bristol Myers Squibb Company, Pfizer Inc., Novartis AG, Teva Pharmaceuticals Ltd., Zydus Pharmaceuticals, Inc., Sun Pharmaceuticals Industries Ltd., and Advanz Pharmaceuticals, along with healthcare providers and technology companies among other global players.
- In August 2022, Tonix Pharmaceuticals Holding Corp. was granted a Cooperative Agreement grant from the National Institute on Drug Abuse to support the development of TNX-1300, a recombinant enzyme for the treatment of cocaine intoxication. Cocaine intoxication causes deleterious effects on several body systems, particularly the cardiovascular system, and can be life-threatening. TNX-1300 has been shown to reverse the physiological effects of i.v. cocaine challenge in people who use cocaine in a prior clinical study. The grant will support the continued development of TNX-1300 as a treatment for life-threatening cocaine intoxication, a condition that caused over 24,900 drug overdose deaths in the U.S. in 2021.
Key Companies Profiled
Tonix Pharmaceutical, GlaxoSmithKline Plc., Bristol Myers Squibb Company, Pfizer Inc., Novartis AG, Teva Pharmaceuticals Ltd., Zydus Pharmaceuticals, Inc., Sun Pharmaceuticals Industries Ltd., and Advanz Pharmaceuticals
Key Segments Profiled in the Cocaine Intoxication Treatment Industry Survey
Drug Class:
- Phentolamine
- Lorazepam
- Diazepam
- Verapamil
- Morphine
Route of Administration:
- Oral
- Inhalation
- Intravenous
- Nasal
Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube